Chimera in Biology: Definition and Examples

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-09-19

A biological chimera is an organism that contains cells originating from two or more zygotes. A zygote is the single cell formed when a sperm fertilizes an egg, so a chimera carries two or more genetically distinct cell lines that started from separate fertilization events, not from a mutation in one embryo.

That definition separates chimerism from two conditions it is often confused with. Mosaicism comes from one zygote and arises when a mutation or chromosome error happens after fertilization, producing genetically different cells within a single lineage. A hybrid comes from two different species or varieties breeding together, so every cell carries a mixed genome rather than two separate genomes sitting side by side. Chimera biology is the study of how these dual-origin organisms form, how they behave, and why they matter in medicine, agriculture, and research.

The Core Definition: Two Zygotes, One Body

The word chimera traces back to Greek mythology, where the Chimera was a monster assembled from parts of a lion, a goat, and a serpent. Modern biology borrowed the name because the concept fits: a single body assembled from genetically different parts. The mythological creature is a useful metaphor and nothing more. A biological chimera is a measurable, testable condition defined by the origin of its cells.

The key criterion is the number of zygotes. If an organism's cells descend from one fertilization event, it is not a chimera, no matter how genetically mixed its tissues look. If its cells descend from two or more fertilization events that later merged or exchanged cells, it is a chimera.

This matters because the genetic signature of chimerism is distinctive. When researchers genotype a chimera, they often find more than the expected two alleles at a given genetic marker. A normal diploid human inherits one allele from each parent at an autosomal short tandem repeat (STR) locus, a short stretch of repeating DNA used for identity testing. A tetragametic chimera can carry three or four alleles at a single locus because two separate embryos contributed DNA [1][2]. That surplus of alleles is one of the clearest molecular fingerprints of the condition.

How Chimerism Arises: Three Routes

Chimerism forms through three broad routes: fusion of embryos, cell transfer between individuals, and deliberate laboratory construction. Each route produces a different pattern of mixed tissues and a different set of practical consequences.

Tetragametic Chimerism: Fusion of Two Embryos

Tetragametic chimerism, sometimes called dispermic chimerism, happens when two separately fertilized embryos fuse into a single developing organism early in development. The name reflects the arithmetic: two eggs fertilized by two sperm create four gametes' worth of genetic contribution, hence "tetragametic."

A 1995 study of a true hermaphrodite with a 46,XX/46,XY karyotype used restriction fragment length polymorphism analysis of the pseudoautosomal region on the sex chromosomes. A normal diploid individual showed two bands, while the patient showed four, with two bands of maternal origin and two of paternal origin. The authors concluded that the two cell lineages came from two genetically different maternal haploid cells fertilized by two different spermatozoa [3]. That is the cleanest possible demonstration of the mechanism.

Tetragametic chimerism does not always produce visible effects. A 2019 case report described an infertile but phenotypically normal male with a 46,XX blood karyotype and normal spermatogenesis. Interphase FISH on buccal and urine samples plus STR analysis across 34 loci revealed divergent karyotypes in different tissues, and the diagnosis was tetragametic chimerism [4]. The authors noted that the phenotypic spectrum of chimerism is variable with no definite genotype-phenotype correlation, so many cases likely go undiagnosed [4].

Microchimerism: Small Numbers of Foreign Cells

Microchimerism is the presence of a small number of cells from one genetically distinct individual inside another. The prefix "micro" signals quantity, not mechanism. These cells can persist for years or decades and can be found in blood, tissues, and immune cell populations.

The best-studied form is maternal-fetal exchange during pregnancy. Bidirectional transfer of cells across the placenta creates a long-term legacy in both mother and child. Maternal microchimerism refers to maternal cells persisting in the offspring, while fetal microchimerism refers to fetal cells persisting in the mother [5]. Transfer continues after birth through breastfeeding, which delivers maternal cells including immune and stem or progenitor populations to the infant [6].

The sources of naturally acquired microchimerism extend beyond a single pregnancy. They include a known or vanished twin, miscarriage or pregnancy termination, an older sibling transferred via the mother, and previous maternal pregnancy loss [5]. The result is a layered landscape that researchers describe as forward, reverse, and horizontal inheritance, with cells acquired from multiple sources at different points across a lifespan [5].

Microchimeric cells are not passive passengers. They integrate into fetal and neonatal tissues and engage functionally, supporting immune maturation and defense against infection while also contributing to autoimmune and inflammatory disease in susceptible hosts [6]. A 2025 expert consensus project organized the field's open questions into seven categories, including function and mechanism, detection, evolution, and the definition of microchimerism itself [7].

Artificial Chimeras: Built in the Laboratory

Researchers create chimeras deliberately to study development, immunology, and disease. The classic technique is the quail-chick graft, in which a piece of tissue from a quail embryo is transplanted into a chick embryo. Because quail cells have a distinctive nucleolar structure, the grafted cells can be tracked as the embryo develops, revealing where those cells migrate and what tissues they form. This approach helped establish fundamental maps of neural crest and limb development.

Modern versions use pluripotent stem cells, which are cells capable of becoming any cell type in the body. Blastocyst complementation introduces donor stem cells into an early embryo that has been engineered to lack a specific tissue. The donor cells fill the empty developmental niche. A 2025 study disrupted the Foxa1 gene in mice to create a niche for nasopharyngeal epithelium, then introduced human pluripotent stem cells with inactivated MYD88. Human cells integrated into 80.00% of Foxa1-deficient embryos, compared with 4.17% in controls [8]. That is a striking demonstration of how precisely a developmental niche can be opened for donor cells.

A Table Comparing Chimera, Mosaic, and Hybrid

Human Tetragametic Chimeras: Real Cases

Human tetragametic chimerism is rare but well documented. The cases share a common thread: an unexpected laboratory result that initially looked like an error.

A 4-year-old boy with developmental hip dysplasia had a preoperative blood group of AB, but his red cells showed atypical "mixed field" agglutination, meaning two populations of red blood cells reacted differently to the same reagent. His parents' blood groups were AB and O, which suggested possible nonparentage. Molecular cloning and genotyping of his ABO locus in leukocytes revealed two heterozygous genotypes, A102/O01 and B101/O01. Other loci each carried three distinct alleles, unambiguously showing transmission of two alleles from his mother at one locus and two from his father at another. The child was a tetragametic chimera [1].

A 41-year-old healthy Caucasian man had an unidentifiable direct AB0 group and a B group by an indirect method, with natural anti-A1 and anti-A2 antibodies. Mixed fields with anti-B and anti-A+B antisera showed B and O cell populations in roughly a 1:1 ratio. He had no history of transfusion or transplantation, so chimerism was suspected. DNA analysis of tissues confirmed tetragametic chimerism from an apparent double parental contribution of nuclei in a phenotypically normal man [9].

A healthy woman with serologic blood group AB had a biologic father with blood group O. Testing of blood, buccal swabs, and nail clippings revealed A, B, and O alleles by molecular typing, and HLA typing identified one paternal and two maternal haplotypes. Both paternal alleles appeared in only 4 of 23 tested STR and VNTR loci. Her karyotype was 46,XX, and her twin children showed no abnormal findings [2].

A 2026 case report described a pregnant woman with mixed-field agglutination during ABO forward typing. Separation of her two red blood cell populations, flow cytometry, ABO genotyping by direct sequencing and PacBio long-read single-molecule real-time sequencing, and STR analysis of blood, buccal swabs, hair follicles, and parental blood all contributed to identifying a 46,XY/46,XX tetragametic chimera [10].

The pattern across these cases is consistent. Tetragametic chimerism often surfaces first as a blood banking puzzle, a mixed-field reaction, or a parentage discrepancy, and only molecular testing reveals the underlying dual origin.

Freemartin Cattle and Other Animal Chimeras

Cattle provide one of the most economically important examples of chimerism. When a female calf is born as a twin to a male calf, the two placentas often fuse in the uterus, allowing blood cell precursors to exchange between the fetuses. The female twin, called a freemartin, receives male cells and typically develops with masculinized or underdeveloped reproductive organs. Freemartinism is a well-recognized cause of infertility in heifers and is routinely screened for in cattle breeding programs.

The freemartin is a natural example of hematopoietic chimerism, meaning the blood-forming system contains cells from two individuals. The condition arises specifically when twins have different sexes, and the female is the one born with the mixed hematopoietic system [11].

The common marmoset, a small New World primate widely used in biomedical research, has a reproductive mode that produces chimerism at high frequency. Marmosets typically give birth to twins, and those twins are hematopoietic chimeras because they share blood cell lineages in the womb. A 2025 population genomics study noted that this frequent twinning and sibling chimerism complicates standard population genetic models that assume independent individuals, because the twins are not genetically independent [12].

Mouse aggregation chimeras are a laboratory staple. Researchers combine cells from two early mouse embryos into a single blastocyst, producing a mouse whose tissues are a patchwork of cells from both donors. These mice have been used for decades to study cell lineage, tissue competition, and developmental timing. The same principle underlies modern blastocyst complementation work with human pluripotent stem cells [8].

Why Chimerism Matters for Parentage Testing

Chimerism can produce DNA test results that look impossible. A child's genotype may appear to exclude a biological parent, or a parent's genotype may appear to exclude a child, even when the relationship is real.

A 2018 case report described a 34-year-old man whose routine blood testing revealed discrepant blood types between parents and baby, and repeat paternity tests excluded him as the father. Microarray technology revealed an avuncular relationship, meaning uncle and nephew, rather than father and son. Additional tissue samples and family studies using STR-based DNA tests confirmed congenital tetragametic chimerism. His paternity was affirmed and the fertility clinic was cleared of a semen sample mix-up [13]. The authors noted that some allegations of fertility clinic errors may be explained by undiagnosed chimerism and suggested improving laboratory reporting and clinical guidelines to help identify such cases [13].

The forensic literature makes the same point. A 2009 case report described a healthy 41-year-old man whose blood group results were uninterpretable until DNA analysis of multiple tissues revealed tetragametic chimerism from a double parental contribution [9]. When only blood is used as the DNA source, chimerism can falsely exclude maternity or paternity [11].

The practical lesson is that a single-tissue DNA sample can mislead. Testing buccal swabs, hair follicles, nail clippings, or skin fibroblasts alongside blood increases the chance of detecting a second cell line. Laboratories that handle parentage and forensic testing increasingly recognize chimerism as a real, if uncommon, explanation for anomalous results.

Why Chimerism Matters for Organ Transplantation

The immune system identifies cells by their human leukocyte antigen (HLA) molecules, proteins on the cell surface that mark a cell as self or foreign. Chimerism scrambles that signal because the body contains cells with more than one HLA profile.

In tetragametic chimerism, the immune system may have developed tolerance to two sets of HLA molecules. That can affect how the body responds to a transplanted organ. A donor organ that matches one of the chimera's cell lines may be tolerated differently than expected, and the reverse is also possible. Studies of iatrogenic chimerism, meaning chimerism created by medical treatment, have established that donor-recipient HLA disparity can provide benefit against recurrent malignancy after transplantation [5].

Microchimerism adds another layer. Maternal cells persisting in an offspring can modulate the tolerance and rejection balance in transplant patients [6]. Fetal cells persisting in a mother can do the same. The clinical implications are still being worked out, and the 2025 expert consensus identified microchimerism in interventions, treatment, and transplant as one of seven major research categories [7].

For transplant matching, the takeaway is that a chimera's HLA type is not a single, stable signature. Testing multiple tissues and interpreting results with chimerism in mind can prevent mismatches and unexplained rejection episodes.

How Chimerism Is Detected

Detection relies on finding more than two alleles at genetic markers, or on finding two distinct cell populations in a single tissue.

The standard toolkit includes:

1. Karyotyping, which examines chromosome number and structure and can reveal two cell lines such as 46,XX and 46,XY in the same person [4][14].
2. Fluorescence in situ hybridization (FISH), which uses labeled probes to count X and Y chromosome signals in individual cells [4][14].
3. Short tandem repeat (STR) analysis, which amplifies highly variable DNA regions and can show three or four alleles at a single locus [1][2][15].
4. HLA typing, which can reveal more than two haplotypes, the sets of HLA genes inherited from each parent [2][14].
5. Blood group serology, which can show mixed-field agglutination when two red blood cell populations react differently to the same reagent [1][9][10].

A 2006 report described two Korean men whose red cells typed as group AB but whose ABO genotype by allele-specific PCR was B/O. Cloning and sequencing revealed three alleles in both: A102/B101/O04 in one and A102/B101/O01 in the other. STR testing across nine loci showed a double paternal and single maternal DNA contribution in one man, indicating chimera or mosaic, and a double paternal contribution in the other [15]. That case illustrates how serology, genotyping, and STR analysis work together.

Common Mistakes and Limitations

Several misunderstandings about chimerism cause confusion in both research and clinical settings.

The first mistake is treating "chimera" as a synonym for "mosaic." They have different origins and different implications. A mosaic arises from one zygote, so parentage testing usually still works. A chimera arises from two or more zygotes, so parentage testing can fail. A 2006 report explicitly noted that chimerism and mosaicism are both important causes of ABO phenotype and genotype discrepancies, and that distinguishing them requires tissue sampling beyond blood [15].

The second mistake is assuming chimerism always causes visible symptoms. Many tetragametic chimeras are phenotypically normal. The 2019 case report described a phenotypically normal male with normal spermatogenesis whose chimerism was found only through fertility investigation [4]. The 2009 case described a healthy 41-year-old man [9]. The 2005 case described a healthy woman with healthy twin children [2].

The third mistake is relying on a single tissue for genetic testing. Chimerism can be unevenly distributed. In the 2005 case, both paternal alleles appeared in only 4 of 23 tested loci [2]. In the 2019 case, divergent karyotypes appeared in different tissues [4]. Testing blood alone can miss the second cell line entirely.

The fourth mistake is overinterpreting microchimerism. The presence of foreign cells does not automatically mean disease. Microchimerism is increasingly recognized as an aspect of normal biology, present in adaptive and innate immune cells, resident tissue-specific cells, and extracellular vesicles [5]. Its role in cancer remains poorly understood, with conflicting results across studies [16].

The fifth limitation is that chimerism research is methodologically constrained. The 2025 expert consensus identified detection methods, appropriate experimental model systems, and even the definition of microchimerism as open questions [7]. Researchers still lack standardized ways to measure microchimeric cell numbers and to track them over time.

Individual cases require professional medical or veterinary evaluation. This guide explains the biology, not the clinical management of any specific patient or animal.

A Diagram of Cell Lineage Origins

The following flowchart shows how a single organism can end up with cells from more than one zygote, and how that differs from mosaicism.

flowchart TD
    A[Fertilization event] --> B{How many zygotes}
    B -->|One zygote| C[Single embryo]
    B -->|Two zygotes| D[Two embryos]
    C --> E[Post zygotic mutation]
    E --> F[Mosaic]
    C --> G[No mutation]
    G --> H[Uniform organism]
    D --> I[Embryo fusion]
    D --> J[Cell transfer between twins]
    I --> K[Tetragametic chimera]
    J --> L[Blood or tissue chimera]
    K --> M[Multiple tissues affected]
    L --> N[Limited tissues affected]

Frequently Asked Questions

What is a chimera in biology?

A chimera is an organism with cells that come from two or more zygotes. The cells are genetically distinct because they started from separate fertilization events.

How is a chimera different from a mosaic?

A mosaic comes from one zygote and develops genetic differences after fertilization through mutation or chromosome error. A chimera comes from two or more zygotes that merged or exchanged cells.

Can a human be a chimera?

Yes. Human tetragametic chimerism is rare but documented in healthy people, including cases discovered through blood typing, fertility testing, and parentage disputes [1][9][2].

What is tetragametic chimerism?

Tetragametic chimerism is the fusion of two separately fertilized embryos into one organism. The name reflects the four gametes involved, two eggs and two sperm [3].

What is microchimerism?

Microchimerism is the presence of a small number of cells from one genetically distinct individual inside another. It commonly occurs between a mother and her child during pregnancy [5].

Why does chimerism affect paternity tests?

Chimerism can make a child's DNA appear to exclude a biological parent. A 2018 case showed a man wrongly excluded as a father until multi-tissue testing confirmed tetragametic chimerism [13].

What is a freemartin?

A freemartin is a female calf born as a twin to a male calf. Shared placental circulation transfers male cells to the female, often causing reproductive abnormalities and infertility [11].

Are chimeras the same as hybrids?

No. A hybrid comes from two species breeding together and has one mixed genome in every cell. A chimera has two or more separate genomes in different cell populations.

Related Articles

• What Is a Buffer in Biology? Definition and Examples
• What Is a Trait in Biology? Definition and Examples
• competition biology example
• Bayes theorem biology examples
• What Is Succession in Biology? Definition and Examples
• Carrying Capacity in Biology: Definition and Examples
• Mutualism Biology Example: Definition and Cases
• Inhibitor Definition: Types and Examples in Biology
• Pronation vs Supination: Definitions and Examples

Sources

1. Congenital tetragametic blood chimerism explains a case of questionable paternity.
2. Tetragametic chimerism detected in a healthy woman with mixed-field agglutination reactions in ABO blood grouping.
3. Molecular biologic analyses of tetragametic chimerism in a true hermaphrodite with 46,XX/46,XY.
4. Rare case of an oligospermic male with 46,XX/46,XY tetragametic chimerism.
5. The when, what, and where of naturally-acquired microchimerism.
6. Maternal microchimerism: foreign friend, hidden enemy.
7. Identifying Key Questions and Challenges in Microchimerism Biology.
8. Foxa1 disruption enhances human cell integration in human-mouse interspecies chimeras.
9. An unusual observation of tetragametic chimerism: forensic aspects.
10. [[Identification of a pregnant woman with tetragametic chimera of 46,XY/46,XX karyotype presenting as mixed agglutination during ABO blood group forward typing].](https://pubmed.ncbi.nlm.nih.gov/42386666/)
11. Chimerism and tetragametic chimerism in humans: implications in autoimmunity, allorecognition and tolerance.
12. Inferring the landscapes of mutation and recombination in the common marmoset ( Callithrix jacchus ) in the presence of twinning and hematopoietic chimerism.
13. A case of chimerism-induced paternity confusion: what ART practitioners can do to prevent future calamity for families.
14. [[The mechanism of tetragametic chimerism in a true hermaphroditism with 46, XX/46 ,XY].](https://pubmed.ncbi.nlm.nih.gov/15027182/)
15. Chimerism and mosaicism are important causes of ABO phenotype and genotype discrepancies.
16. The duality of microchimerism and cancer in parous women: a review and evolutionary perspective.